Chronic rhinosinusitis (CRS) is inflammation of the paranasal sinuses and nasal passages that affects 5-15% of populations in Europe and the United States. The prevalence varies substantially worldwide from 1.0% to 12.1% and increases with age until around 60 years old. CRS can be divided into types based on symptom duration, such as acute rhinosinusitis lasting less than 4 weeks, subacute lasting 4-12 weeks, and chronic lasting more than 12 weeks.
Chronic rhinosinusitis (CRS) is inflammation of the paranasal sinuses and nasal passages that affects 5-15% of populations in Europe and the United States. The prevalence varies substantially worldwide from 1.0% to 12.1% and increases with age until around 60 years old. CRS can be divided into types based on symptom duration, such as acute rhinosinusitis lasting less than 4 weeks, subacute lasting 4-12 weeks, and chronic lasting more than 12 weeks.
Chronic rhinosinusitis (CRS) is inflammation of the paranasal sinuses and nasal passages that affects 5-15% of populations in Europe and the United States. The prevalence varies substantially worldwide from 1.0% to 12.1% and increases with age until around 60 years old. CRS can be divided into types based on symptom duration, such as acute rhinosinusitis lasting less than 4 weeks, subacute lasting 4-12 weeks, and chronic lasting more than 12 weeks.
Chronic rhinosinusitis (CRS) is inflammation of the paranasal sinuses and nasal passages that affects 5-15% of populations in Europe and the United States. The prevalence varies substantially worldwide from 1.0% to 12.1% and increases with age until around 60 years old. CRS can be divided into types based on symptom duration, such as acute rhinosinusitis lasting less than 4 weeks, subacute lasting 4-12 weeks, and chronic lasting more than 12 weeks.
INTRODUCTION than 4 times a year, with total resolution
between attack intervals. Meanwhile, acute
Rhinosinusitis is a disease that is exacerbation of chronic rhinosinusitis is a often found and affects the quality of life sudden worsening of the symptoms of and health of individuals which in turn will patients, who have been diagnosed with have an impact on economic and chronic rhinosinusitis, such as early employment problems (Rosenfeld et al. symptoms before being given treatment 2015). (Bailey et al. 2014). Rhinosinusitis is inflammation of Prevalence for CRS varies the paranasal sinuses and nasal mucosa, substantially with rates ranging from 1.0% which is characterized by symptoms to 12.1% across the world (Xu et al. 2016). of nasal congestion, the presence of Chronic rhinosinusitis affects 5-15% of nasal secretions from both anterior and the population in Europe and the United posterior nasal drips, accompanied by States with an increasing prevalence with symptoms of spontaneous facial pain or increasing age, with a mean of 2.7% in the compression in the sinus area and 20- 29 age group and 6.6% 50-59 years. decreased or lost smell (Rosenfeld et al. After 60 years of age, the prevalence rate 2015). of CRS decreases to 4.7% (Fokkens et al. Rhinosinusitis is divided into 2020). The prevalence of CRS varies in several types according to the duration of Asian countries. A review revealed that symptoms felt by the patient based on the the prevalence of CRS in Asia ranged classification made by the Task Force of widely from 2.1 to 28.4%. South Korea The American Academy of established the Korea National Health and Otolaryngology-Head and Neck Surgery Nutrition Survey (KNHNS) and published (AAO-HNS), namely: acute rhinosinusitis, a series of studies about the prevalence and subacute rhinosinusitis, chronic risk factors of CRS in recent years. The rhinosinusitis, chronic rhinosinusitis acute prevalence of CRS was 6.95% among exacerbation, and recurrent acute 4,098 subjects, and the risk factors for rhinosinusitis. Acute rhinosinusitis lasts no CRS included heavy stress, influenza more than 4 weeks. Sub-acute vaccination, septal deviation, and rhinosinusitis, lasting between 4-12 weeks. persistent allergic rhinitis (AR). While in Chronic rhinosinusitis can last more than 12 2008–2012, the prevalence of CRSwNP weeks. Recurrent acute rhinosinusitis, is a and CRSsNP in 28,912 adults was 2.6 and symptom experienced by the patient more 5.8%, respectively, in 2010–2012, the